Product Description
Overall, the global dental barrier membrane market was valued at nearly $590 million in 2023. This is expected to increase over the forecast period at a CAGR of 7.7% to reach over $988 million.
The full report suite on the global market for dental barrier membranes includes segments for resorbable and non-resorbable products, as well as segments for allografts, xenografts and synthetic barrier membrane products.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Dental Barrier Membrane Market Insights 
Global Dental Barrier Membrane Market Share Insights 
- Geistlich led the global dental barrier membrane market in 2023 with its Bio-Gide® collagen membrane product line, including Bio-Gide® Perio, which offers improved handling for periodontal procedures. Geistlich also bundles its collagen membranes with Bio-Oss Collagen® xenograft to strengthen its market position.
- Zimmer Biomet held the second spot, leveraging its presence in the dental implant and bone graft substitute markets. Its portfolio, including the OsseoGuard® non-resorbable membranes, designed to prevent bacterial infiltration and tissue growth into the bone cavity, continues to grow.
- Envista ranked third, thanks to its dominance in the non-resorbable segment, bolstered by acquiring Osteogenics Biomedical in 2022. Envista’s comprehensive product portfolio, featuring the Cytoplast™ line and other regenerative products, ensures its strong market position and broad reach among dental professionals.
Market Segmentation Summary
- Dental Barrier Membranes – Includes:
- By Type: Resorbable, Non-Resorbable
- By Material: Allograft, Xenograft, Synthetic
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2020 |
| Historical Data | 2020-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
